Skip to main content

Headlines

Fed’s preferred gauge showed core inflation at 3.0% in August, much lighter than expected
posted:
by: CNBC US News
#channels:: #All, #News, #USA, #CNBCUSNews, #CNBC
Silexion Doses First Patient In Phase 2/3 SIL204 Trial For Pancreatic Cancer
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Ken Griffin pledges $3 billion to Carnegie Mellon University in 'historic' gift
posted:
by: CNBC Top Stories
#channels:: #All, #CNBCTopStories, #News, #CNBC, #Popular, #Latest, #World
Boeing rises 3% after securing U.S. Navy deal to develop next-generation fighter jet
posted:
by: CNBC World News
#channels:: #All, #News, #World, #CNBC, #CNBCWorldNews
Where Will Dell Technologies Be in 3 Years?
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Recession Fears Are Back. These 3 Steps Can Prepare Your Investments for a Bear Market
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Prediction: This Is What a $1,000 Investment in XRP Will Be Worth in 3 Years
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
3 Tech Stocks That Could Be in Trouble if There's an Artificial Intelligence (AI) Slowdown
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Rafael Reports Phase 3 Trappsol Cyclo Data In NPC
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Warren Buffett's Successor, Greg Abel, Has Over $42 Billion of Berkshire Hathaway's Capital Invested in 3 Virtual Monopolies
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Hedge fund CEO Ken Griffin donates $3 billion to Carnegie Mellon as part of his bet on Florida
posted:
by: CNN Most Recent
#channels:: #All, #World, #Latest, #News, #CNN
These 3 AI Stocks Are Poised to Be Big Winners from Amazon's Choice to Block Meta's Muse
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Takeda Says Zasocitinib Tops Deucravacitinib With Superior Skin Clearance In Phase 3 Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Roche Unveils Newborn Screening Test For 3 Genetic Conditions Of SMA, SCID, Sickle Cell Disease
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Takeda's Zasocitinib Shows Superior Skin Clearance In Phase 3 Psoriasis Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks